RBOT

MKT CAP:$8M

Vicarious Surgical Inc.

Market Cap

$8M

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Healthcare·Medical - Devices·🇺🇸·NYSE

Stock Price

$0.70-$1.82 (-72.14%)

Apr 21, 2026

Company Details

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical rob...

CEO

Stephen From

IPO Date

Sep 4, 2020

Website

www.vicarioussurgical.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$50M

EPS (Diluted)

-$8.26

Free Cash Flow

-$45M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q1 2026

May 11, 2026

PENDING

FY 2025

Mar 9, 2026

$0EPS -$8.45

Q4 2025

Mar 9, 2026

$0EPS -$1.57

Q3 2025

Nov 12, 2025

$0EPS -$1.86

Q2 2025

Aug 12, 2025

$0EPS -$2.23

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	$0	-$18M
Q2 22	$0	$0	-$19M
Q3 22	$0	$0	-$22M
Q4 22	$0	$0	-$21M
Q1 23	$0	$0	-$22M
Q2 23	$0	$0	-$21M
Q3 23	$0	$0	-$21M
Q4 23	$0	-$525.0K	-$16M
Q1 24	$0	$0	-$16M
Q2 24	$0	$0	-$18M
Q3 24	$0	$0	-$18M
Q4 24	$0	-$542.0K	-$15M
Q1 25	$0	$0	-$16M
Q2 25	$0	$0	-$14M
Q3 25	$0	-$352.0K	-$12M
Q4 25	$0	-$291.0K	-$10M

Valuation

Quarter	P/S	P/E
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	50.6x
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$15M	-$17M
Q2 22	-$14M	-$16M
Q3 22	-$14M	-$15M
Q4 22	-$18M	-$19M
Q1 23	-$19M	-$19M
Q2 23	-$15M	-$15M
Q3 23	-$17M	-$17M
Q4 23	-$11M	-$12M
Q1 24	-$14M	-$14M
Q2 24	-$11M	-$11M
Q3 24	-$13M	-$13M
Q4 24	-$12M	-$12M
Q1 25	-$12M	-$12M
Q2 25	-$13M	-$13M
Q3 25	-$10M	-$11M
Q4 25	-$9M	-$9M

Capital Expenditures

Quarter	CapEx
Q1 22	$2M
Q2 22	$2M
Q3 22	$782.0K
Q4 22	$992.0K
Q1 23	$306.0K
Q2 23	$208.0K
Q3 23	$118.0K
Q4 23	$1M
Q1 24	$10.0K
Q2 24	$6.0K
Q3 24	$16.0K
Q4 24	$180.0K
Q1 25	$5.0K
Q2 25	$8
Q3 25	$116.7K
Q4 25	$10.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+380.4%
Q2 22	—	+265.6%
Q3 22	—	+235.2%
Q4 22	—	+140.7%
Q1 23	—	+22.7%
Q2 23	—	+12.2%
Q3 23	—	-3.7%
Q4 23	—	-24.6%
Q1 24	—	-27.8%
Q2 24	—	-17.5%
Q3 24	—	-16.8%
Q4 24	—	-3.6%
Q1 25	—	-2.2%
Q2 25	—	-23.7%
Q3 25	—	-35.2%
Q4 25	—	-31.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$2M	—
Q2 22	$3M	—
Q3 22	$4M	—
Q4 22	$4M	—
Q1 23	$3M	—
Q2 23	$3M	—
Q3 23	$4M	—
Q4 23	$3M	—
Q1 24	$3M	—
Q2 24	$3M	—
Q3 24	$3M	—
Q4 24	$3M	—
Q1 25	$3M	—
Q2 25	$0	—
Q3 25	$0	—
Q4 25	$1M	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$10M	$7M	$1M	—
Q2 22	$10M	$8M	$1M	—
Q3 22	$12M	$8M	$2M	—
Q4 22	$12M	$7M	$2M	—
Q1 23	$13M	$7M	$2M	—
Q2 23	$13M	$7M	$2M	—
Q3 23	$13M	$7M	$1M	—
Q4 23	$8M	—	—	$7M
Q1 24	$10M	$5M	$1M	—
Q2 24	$11M	$6M	$1M	—
Q3 24	$11M	$6M	$1M	—
Q4 24	$8M	—	—	$7M
Q1 25	$9M	$5M	$1M	—
Q2 25	$9M	$4M	$349.0K	—
Q3 25	$8M	$3M	$350.0K	—
Q4 25	$7M	$3M	$431.0K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$157M	$0	$157M
Q2 22	$141M	$0	$141M
Q3 22	$127M	$0	$127M
Q4 22	$116M	$0	$116M
Q1 23	$54M	$43M	$98M
Q2 23	$33M	$50M	$83M
Q3 23	$59M	$51M	$110M
Q4 23	$53M	$45M	$98M
Q1 24	$38M	$46M	$84M
Q2 24	$20M	$53M	$73M
Q3 24	$7M	$54M	$61M
Q4 24	$10M	$39M	$49M
Q1 25	$3M	$35M	$37M
Q2 25	$4M	$20M	$24M
Q3 25	$3M	$10M	$13M
Q4 25	$3M	$7M	$10M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	4M	+38.4%	+46.7%
Q2 22	4M	-4.9%	-99.9%
Q3 22	4M	+0.5%	+38.8%
Q4 22	4M	+1.3%	+33.9%
Q1 23	4M	+2.1%	-1.2%
Q2 23	4M	+0.7%	+4.7%
Q3 23	5M	+22.2%	+27.2%
Q4 23	6M	+12.9%	+41.8%
Q1 24	5M	-7.9%	+27.9%
Q2 24	6M	+9.4%	+38.9%
Q3 24	6M	+0.5%	+14.2%
Q4 24	6M	+0.2%	+1.4%
Q1 25	6M	+0.2%	+10.3%
Q2 25	6M	+0.2%	+1.1%
Q3 25	6M	0.0%	+0.6%
Q4 25	7M	+12.8%	+13.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$0	165
Q2 22	$0	165
Q3 22	$0	165
Q4 22	$0	213
Q1 23	$0	213
Q2 23	$0	213
Q3 23	$0	213
Q4 23	$0	131
Q1 24	$0	131
Q2 24	$0	131
Q3 24	$0	131
Q4 24	$0	123
Q1 25	$0	123
Q2 25	$0	123
Q3 25	$0	123
Q4 25	$0	127

Revenue / Employee